Earnings History Data for Antares Pharma, Inc. (ATRS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Antares Pharma, Inc.

Antares Pharma, Inc. develops, commercializes and markets novel delivery solutions, including needle-free and mini-needle injector systems, gel technologies and transdermal products, which improve both the efficiency of drug therapies and the quality of life for patients. The Company currently distributes its needle-free injector systems for the delivery of insulin and growth hormone in over 20 countries and an estradiol transdermal patch for hormone replacement therapy.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
03-03-2022	PM	7:00 AM ET (Mar 3)	ATRS	Antares Pharma, Inc.	595.15	0.02	0.01	0.03	Antares Pharma Non-GAAP EPS of $0.02 beats by $0.01, revenue of $48.73M beats by $1.54M [3/3/2022 7:01 AM]	3.81	0.27 (7.63%)	3.69	0.15 (4.24%)	3.11 - 4.63	912,401	560,000	6,982
Antares Pharma Non-GAAP EPS of $0.02 beats by $0.01, revenue of $48.73M beats by $1.54M [3/3/2022 7:01 AM] Antares Pharma Reports Fourth Quarter and Full-Year 2021 Financial and Operating Results [Mar-03-22 07:00AM] Antares Pharma (ATRS) Surpasses Q4 Earnings and Revenue Estimates [Mar-03-22 08:15AM]
04-11-2021	PM	7:00 AM ET (Nov 4)	ATRS	Antares Pharma, Inc.	644.18	0.03	0.03	0.03	Antares Pharma EPS in-line, beats on revenue [11/4/2021 7:03 AM]	3.66	-0.26 (-6.63%)	3.66	0.0 (0.00%)	2.79 - 5.07	1,195,851	610,000	6,759
Antares Pharma Q3 2021 Earnings Preview [11/3/2021 11:20 AM] Antares Pharma EPS in-line, beats on revenue [11/4/2021 7:03 AM] Antares Pharma Reports Third Quarter 2021 Financial and Operating Results [Nov-04-21 07:00AM] Antares Pharma (ATRS) Q3 Earnings Match Estimates [Nov-04-21 08:35AM]
05-08-2021	PM	7:00 AM ET (Aug 5)	ATRS	Antares Pharma, Inc.	739.34	0.03	0.02	0.01	Antares Pharma EPS beats by $0.01, beats on revenue [8/5/2021 7:02 AM]	4.23	-0.03 (-0.65%)	4.37	0.11 (2.58%)	2.57 - 5.07	509,551	600,000	5,828
Antares Pharma EPS beats by $0.01, beats on revenue [8/5/2021 7:02 AM] Antares Pharma Reports Second Quarter 2021 Financial and Operating Results [Aug-05-21 07:00AM]
06-05-2021	PM	7:00 AM ET (May 6)	ATRS	Antares Pharma, Inc.	632.99	0.02	0.02	-0.01	Antares Pharma EPS beats by $0.01, beats on revenue [5/6/2021 7:06 AM]	3.60	-0.19 (-5.01%)	3.60	0.0 (0.00%)	2.39 - 5.07	910,653	590,000	7,865
Antares Pharma EPS beats by $0.01, beats on revenue [5/6/2021 7:06 AM] Antares Pharma posts Q1 earnings beat, maintains FY revenue forecast [5/6/2021 8:00 AM] Antares Pharma, Inc. to Host Earnings Call [May-06-21 06:45AM] Antares Pharma Reports First Quarter 2021 Financial and Operating Results [May-06-21 07:00AM] Antares Pharma Appoints Joseph Renda as Senior Vice President of Commercial [May-06-21 07:15AM] Antares Pharma (ATRS) Meets Q1 Earnings Estimates [May-06-21 09:25AM]
02-03-2021	PM	7:00 AM ET (Mar 2)	ATRS	Antares Pharma, Inc.	708.36	0.03	0.04	0.03	Antares Pharma EPS beats by $0.26, beats on revenue; reaffirms guidance [3/2/2021 7:04 AM]	4.08	-0.42 (-9.22%)	4.52	0.02 (0.44%)	1.60 - 5.07	3,006,707	1,871,805	8,666
Antares Pharma EPS beats by $0.26, beats on revenue; reaffirms guidance [3/2/2021 7:04 AM] Antares Pharma (ATRS) Q4 Earnings Lag Estimates [Mar-02-21 08:25AM] Recap: Antares Pharma Q4 Earnings [Mar-02-21 07:22AM] Antares Pharma Reports Fourth Quarter and Full-Year 2020 Financial and Operating Results [Mar-02-21 07:00AM]
05-11-2020	PM	7:00 AM ET (Nov 5)	ATRS	Antares Pharma, Inc.	493.30	0.03	0.03	0.01	Antares Pharma EPS in-line, beats on revenue [11/5/2020 7:05 AM]	3.05	0.04 (1.33%)	3.05	0.0 (0.00%)	1.60 - 5.13	1,201,375	846,693	32,663

06-08-2020	PM	7:00 AM ET (Aug 6)	ATRS	Antares Pharma, Inc.	465.22	0.01	0.00	-0.01	Antares Pharma EPS beats by $0.01, beats on revenue [8/6/2020 7:01 AM]	2.93	-0.07 (-2.30%)	3.09	0.09 (3.00%)	1.60 - 5.13	1,279,368	834,576	61,314

05-05-2020	PM	7:00 AM ET (May 5)	ATRS	Antares Pharma, Inc.	533.10	-0.01	0.00	-0.03	Antares Pharma EPS misses by $0.01, beats on revenue [5/5/2020 7:03 AM]	2.82	-0.47 (-14.29%)	3.05	-0.24 (-7.29%)	1.60 - 5.13	1,489,950	1,204,589	221,975